series-c-plus
Stage
3
Investors
About
Iaso Therapeutics is a biotechnology company developing V-cell-based immunotherapies for the treatment of cancer. The company's proprietary i-Engine platform engineers V-cells to target and eliminate cancer cells.
Explore Iaso Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.